Human Genome Epidemiology Literature Finder
|
Records 1 - 9 (of 9 Records) |
| Query Trace: Neoplasms and HSD3B2[original query] |
|---|
| Joint effect of HSD3B1 and HSD3B2 genes is associated with hereditary and sporadic prostate cancer susceptibility. Cancer research 2002 Mar 62 (6): 1784-9. Chang Bao-li, Zheng Siqun L, Hawkins Gregory A, Isaacs Sarah D, Wiley Kathy E, Turner Aubrey, Carpten John D, Bleecker Eugene R, Walsh Patrick C, Trent Jeffrey M, Meyers Deborah A, Isaacs William B, Xu Jianfe |
| Variants in estrogen biosynthesis genes, sex steroid hormone levels, and endometrial cancer: a HuGE review. American journal of epidemiology 2007 Feb 165 (3): 235-45. Olson Sara H, Bandera Elisa V, Orlow Ire |
| SRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness. The Prostate 2007 Nov 67 (15): 1654-63. Neslund-Dudas Christine, Bock Cathryn H, Monaghan Kristin, Nock Nora L, Yang James J, Rundle Andrew, Tang Deliang, Rybicki Benjamin |
| Evaluation of genetic variations in the androgen and estrogen metabolic pathways as risk factors for sporadic and familial prostate cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007 May 16 (5): 969-78. Cunningham Julie M, Hebbring Scott J, McDonnell Shannon K, Cicek Mine S, Christensen G Bryce, Wang Liang, Jacobsen Steven J, Cerhan James R, Blute Michael L, Schaid Daniel J, Thibodeau Stephen |
| Variant in sex hormone-binding globulin gene and the risk of prostate cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007 Jan 16 (1): 165-8. Berndt Sonja I, Chatterjee Nilanjan, Huang Wen-Yi, Chanock Stephen J, Welch Robert, Crawford E David, Hayes Richard |
| Single and multigenic analysis of the association between variants in 12 steroid hormone metabolism genes and risk of prostate cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009 Jun 18 (6): 1869-80. Beuten Joke, Gelfond Jonathan A L, Franke Jennifer L, Weldon Korri S, Crandall Analisa C, Johnson-Pais Teresa L, Thompson Ian M, Leach Robin |
| HSD3B and gene-gene interactions in a pathway-based analysis of genetic susceptibility to bladder cancer. PloS one 2012 7 (12): 12. Andrew AS, Hu T, Gu J, Gui J, Ye Y, Marsit CJ, Kelsey KT, Schned AR, Tanyos SA, Pendleton EM, Mason RA, Morlock EV, Zens MS, Li Z, Moore JH, Wu X, Karagas MR |
| CYP11A1 expression in bone is associated with aromatase inhibitor-related bone loss. Journal of molecular endocrinology 2015 Aug 55 (1): 69-79. Rodríguez-Sanz M, García-Giralt N, Prieto-Alhambra D, Servitja S, Balcells S, Pecorelli R, Díez-Pérez A, Grinberg D, Tusquets I, Nogués |
| Variable expression quantitative trait loci analysis of breast cancer risk variants. Scientific reports 2021 3 11 (1): 7192. Wiggins George A R, Black Michael A, Dunbier Anita, Merriman Tony R, Pearson John F, Walker Logan |
- Page last reviewed:Feb 1, 2024
- Content source: